Literature DB >> 11096506

Acute Transmural Myocardial Infarction.

.   

Abstract

Patients with transmural (with ST segment elevation) myocardial infarction should immediately be considered for reperfusion therapy. Fibrinolytic therapy with streptokinase, alteplase, or reteplase should be started within 30 minutes of presentation for patients without bleeding risk. Alternatively, patients at tertiary care hospitals can undergo emergency coronary angioplasty. Other lifesaving pharmacologic interventions include administering aspirin, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. Oxygen, morphine sulfate, heparin, and nitroglycerin are also useful. No benefit has been demonstrated for calcium channel blockers, magnesium, or prophylactic lidocaine. Patients need to be closely monitored for conduction abnormalities, arrhythmias, and heart failure.

Entities:  

Year:  2000        PMID: 11096506     DOI: 10.1007/s11936-000-0024-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  9 in total

Review 1.  Coronary stent implantation in acute myocardial infarction.

Authors:  R H Mehta; E R Bates
Journal:  Am Heart J       Date:  1999-04       Impact factor: 4.749

Review 2.  Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials.

Authors:  C H Hennekens; C M Albert; S L Godfried; J M Gaziano; J E Buring
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

Review 3.  Thrombolysis for acute myocardial infarction.

Authors:  H D White; F J Van de Werf
Journal:  Circulation       Date:  1998-04-28       Impact factor: 29.690

Review 4.  Platelet glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction.

Authors:  E R Bates
Journal:  Curr Opin Cardiol       Date:  1998-07       Impact factor: 2.161

Review 5.  Emergency department: rapid identification and treatment of patients with acute myocardial infarction. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group.

Authors: 
Journal:  Ann Emerg Med       Date:  1994-02       Impact factor: 5.721

6.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

7.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; E M Antman; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B Riegel; R O Russell; E E Smith; W D Weaver; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; A Garson; G Gregoratos; T J Ryan; S C Smith
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

8.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

Review 9.  Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.

Authors:  S Yusuf; P Sleight; P Held; S McMahon
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

  9 in total
  1 in total

Review 1.  Sonothrombolysis.

Authors:  Kenneth B Bader; Guillaume Bouchoux; Christy K Holland
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.